Your browser doesn't support javascript.
loading
Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer.
Posch, Florian; Silina, Karina; Leibl, Sebastian; Mündlein, Axel; Moch, Holger; Siebenhüner, Alexander; Samaras, Panagiotis; Riedl, Jakob; Stotz, Michael; Szkandera, Joanna; Stöger, Herbert; Pichler, Martin; Stupp, Roger; van den Broek, Maries; Schraml, Peter; Gerger, Armin; Petrausch, Ulf; Winder, Thomas.
Afiliação
  • Posch F; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz, Austria.
  • Silina K; Tumor Immunology Research Unit, Institute of Experimental Immunology, University of Zurich, Winterthurerstrasse 190, Zurich, Switzerland.
  • Leibl S; Department of Pathology and Molecular Pathology, University Hospital Zurich, Schmelzbergstrasse 12, Zürich, Switzerland.
  • Mündlein A; Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Carinagasse 47, Feldkirch, Austria.
  • Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich, Schmelzbergstrasse 12, Zürich, Switzerland.
  • Siebenhüner A; Department of Oncology, University Hospital Zurich, Rämistrasse 100, Zürich, Switzerland.
  • Samaras P; Department of Oncology, University Hospital Zurich, Rämistrasse 100, Zürich, Switzerland.
  • Riedl J; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz, Austria.
  • Stotz M; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz, Austria.
  • Szkandera J; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz, Austria.
  • Stöger H; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz, Austria.
  • Pichler M; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz, Austria.
  • Stupp R; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • van den Broek M; Department of Oncology, University Hospital Zurich, Rämistrasse 100, Zürich, Switzerland.
  • Schraml P; Tumor Immunology Research Unit, Institute of Experimental Immunology, University of Zurich, Winterthurerstrasse 190, Zurich, Switzerland.
  • Gerger A; Department of Pathology and Molecular Pathology, University Hospital Zurich, Schmelzbergstrasse 12, Zürich, Switzerland.
  • Petrausch U; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz, Austria.
  • Winder T; Department of Oncology, University Hospital Zurich, Rämistrasse 100, Zürich, Switzerland.
Oncoimmunology ; 7(2): e1378844, 2018.
Article em En | MEDLINE | ID: mdl-29416939
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article